Michael Tollini

Cooley advised Cara Therapeutics, Inc. on its $40 million royalty interest purchase and sale agreement with HealthCare Royalty Partners. Michael Tollini and Addison Pierce led the Cooley team advising Cara, which included Bin Wang, Xueqing Li and Jordan Verrilli. Cara, which trades on The NASDAQ Global Market as “CARA,” is a clinical-stage biotech company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors.

Cooley advised Fontainebleau Aviation, a part of Fontainebleau Development’s luxury services division, on its partnership with Skyservice Business Aviation.

Cooley advised Nuvolo, a leader in modern, cloud-based connected workplace solutions, on its definitive agreement to be acquired by climate innovator Trane Technologies.

Cooley advised NETSTREIT on a $250 million sustainability-linked senior unsecured term loan facility agented by Truist Bank, as well as the amendment and extension of its existing $175 million senior unsecured term loan agented by Wells Fargo Bank. NETSTREIT is a real estate investment trust based in Dallas, Texas, that acquires single-tenant net lease retail properties across the US. Michael Tollini, Christina Roupas, Addison Pierce, Sai Yarramalla, Margaret Barreto and Leah Duncan led the Cooley team.

Cooley advised Reata Pharmaceuticals on a $275 million debt financing from funds managed by Pharmakon Advisors, and on an amendment and restatement of its development and commercialization funding agreement with affiliates of Blackstone Life Sciences. Reata – a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases –trades on the Nasdaq Global Market under the symbol RETA. Lawyers Michael Tollini, Mischi a Marca, Addison Pierce, Kelsey Watkins and Xueqing Li led the Cooley team.